home / stock / sls / sls news

SLS News and Press, SELLAS Life Sciences Group Inc. From 08/22/23

Stock Information
Company Name: SELLAS Life Sciences Group Inc.
Stock Symbol: SLS
Market: NASDAQ
Website: sellaslifesciences.com
Menu
SLS SLS Quote SLS Short SLS News SLS Articles SLS Message Board
Get SLS Alerts

News, Short Squeeze, Breakout and More Instantly...
SLS - SELLAS Life Sciences Independent Data Monitoring Committee Recommends Galinpepimut-S REGAL Trial to Continue Without any Modifications

REGAL Interim Analysis Expected by Late 2023/Early 2024 Enrollment Expected to be Completed in Q4 2023 NEW YORK, Aug. 22, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical bi...
SLS - SELLAS Life Sciences GAAP EPS of -$0.31

2023-08-10 17:17:09 ET SELLAS Life Sciences press release ( NASDAQ: SLS ): Q2 GAAP EPS of -$0.31. As of June 30, 2023, cash and cash equivalents totaled approximately $13.8 million. For further details see: SELLAS Life Sciences GAAP EPS of -$0.31

SLS - SELLAS Life Sciences Provides Business Update and Reports Second Quarter 2023 Financial Results

First Patients Dosed in Phase 2a Clinical Trial of SLS009 (formerly GFH009) in Acute Myeloid Leukemia with Topline Data Expected in 4Q 2023 Phase 3 REGAL Study of Galinpepimut-S in Patients with Acute Myeloid Leukemia on Track for Interim Analysis by Late 2023/Early 2024 REGAL I...

SLS - Solaris Reports 105m of 0.60% CuEq and 132m of 0.60% CuEq from Near Surface; Continued Expansion of Warintza East and Warintza Southeast

VANCOUVER, British Columbia, July 24, 2023 (GLOBE NEWSWIRE) -- Solaris Resources Inc . (TSX: SLS; OTCQB: SLSSF) (“Solaris” or the “Company”) is pleased to report assay results from a series of holes aimed at growing mineral resources at the Warintza Project (ȁ...
SLS - SELLAS Life Sciences Reports Positive Data in Completed Phase 1 Study of Galinpepimut-S Combined with Opdivo® in Advanced Malignant Pleural Mesothelioma

Primary Endpoint of Safety and Efficacy Endpoint Both Met with Clinical Activity and Increased Survival Observed 70.3 Weeks Median Overall Survival for Patients Treated with Combination Therapy with 40% of Patients Alive as of Last Follow-Up; Median Overall Survival in Relapsed/Refracto...

SLS - Solaris Reports 54m of 0.80% CuEq from Surface in Northwest Step-Out at Warintza Central; 268m of 0.60% CuEq within 830m averaging 0.50% CuEq in Northeast Step-Out

VANCOUVER, British Columbia, June 28, 2023 (GLOBE NEWSWIRE) -- Solaris Resources Inc . (TSX: SLS; OTCQB: SLSSF) (“Solaris” or the “Company”) is pleased to report assay results from a series of holes aimed at growing the ‘Indicative Starter Pit’ within...

SLS - Solaris Announces Results of Annual General Meeting of Shareholders

VANCOUVER, British Columbia, June 23, 2023 (GLOBE NEWSWIRE) -- Solaris Resources Inc . (TSX: SLS; OTCQB: SLSSF) (“Solaris” or the “Company”) announces that all matters presented for approval at Solaris’ annual meeting of shareholders held today, as more part...
SLS - SELLAS Announces First Patient Dosed in Phase 2a Clinical Trial of GFH009 in Acute Myeloid Leukemia

NEW YORK, June 22, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today ...

SLS - SELLAS Life Sciences Announces Abstract Accepted for Presentation at International Gynecologic Cancer Society Annual Meeting

NEW YORK, June 15, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for a broad range of cancer indications, today ...

SLS - Solaris Reports Significant New Porphyry Discovery in First Hole at Patrimonio, Second and Third Holes Underway and Additional Rigs Being Mobilized

VANCOUVER, British Columbia, June 14, 2023 (GLOBE NEWSWIRE) -- Solaris Resources Inc . (TSX: SLS; OTCQB: SLSSF) (“Solaris” or the “Company”) is pleased to announce the discovery of a significant new porphyry deposit in the first reconnaissance drill hole at the Pat...
Previous 10 Next 10